Actionable insights straight to your inbox

Equities logo

Biotech Sector Turns Red-Hot on Alzheimer’s Treatment News

In Phase 3 trials, a Biogen / Eisai Alzheimer’s drug slowed cognitive decline by 27%.
Mark my words: We are headed for very big trouble ahead, and all because the Fed thinks it can print its way out of any crisis.
Both the truck transportation and durable goods manufacturing sectors lost jobs in September, even as the economy added jobs overall.